Cell Death or Survival Promoted by Alternative Isoforms of ErbB4

The report demonstrates that two distinct isoforms of the ErbB4 receptor tyrosine kinase stimulate either proliferation or apoptosis by mechanisms involving differential transcriptional regulation of the PDGFRA gene. These data have implications for developing approaches to target ErbB4 signaling in cancer.

[1]  Melissa A. Sandahl,et al.  ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo , 2009, Molecular and Cellular Biology.

[2]  R. Harris,et al.  Nedd4 mediates ErbB4 JM‐a/CYT–1 ICD ubiquitination and degradation in MDCK II cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  N. Hynes,et al.  ErbB receptors and signaling pathways in cancer. , 2009, Current opinion in cell biology.

[4]  M. Sliwkowski,et al.  Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms , 2009, Oncogene.

[5]  Melissa A. Sandahl,et al.  The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for Degradation , 2008, Molecular and Cellular Biology.

[6]  F. Jones.  HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.

[7]  Sami Kilpinen,et al.  Role of ErbB4 in Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.

[8]  C. Croce,et al.  Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms , 2008, Proceedings of the National Academy of Sciences.

[9]  Y. Yarden,et al.  Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains , 2007, Oncogene.

[10]  G. Cesareni,et al.  The FASEB Journal • Research Communication The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation , 2022 .

[11]  B. Ford,et al.  Neuregulin-1 Attenuates Neointimal Formation following Vascular Injury and Inhibits the Proliferation of Vascular Smooth Muscle Cells , 2007, Journal of Vascular Research.

[12]  G. Corfas,et al.  Presenilin-Dependent ErbB4 Nuclear Signaling Regulates the Timing of Astrogenesis in the Developing Brain , 2006, Cell.

[13]  Melissa A. Sandahl,et al.  Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1 , 2006, Molecular and Cellular Biology.

[14]  Stuart Thomson,et al.  Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib. , 2006, Cancer research.

[15]  J. Bartlett,et al.  The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. , 2006, Cancer research.

[16]  B. Zetter,et al.  Cancer biomarkers: knowing the present and predicting the future. , 2005, Future oncology.

[17]  Jorma Isola,et al.  Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. , 2005, Molecular biology of the cell.

[18]  G. Carpenter,et al.  Secretase-dependent Tyrosine Phosphorylation of Mdm2 by the ErbB-4 Intracellular Domain Fragment* , 2005, Journal of Biological Chemistry.

[19]  A. West,et al.  A human ImmunoChip cDNA microarray provides a comprehensive tool to study immune responses. , 2005, Journal of immunological methods.

[20]  Y. Pekarsky,et al.  WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. , 2005, Cancer research.

[21]  H. Earp,et al.  The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells , 2005, Breast Cancer Research.

[22]  L. Marrero,et al.  Presenilin-dependent γ-Secretase Processing Regulates Multiple ERBB4/HER4 Activities* , 2005, Journal of Biological Chemistry.

[23]  J. Isola,et al.  Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. , 2005, Cancer research.

[24]  Frank E. Jones,et al.  The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone , 2004, The Journal of cell biology.

[25]  Y. Pekarsky,et al.  Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Khachigian,et al.  Fibroblast Growth Factor-2 Represses Platelet-derived Growth Factor Receptor-α (PDGFR-α) Transcription via ERK1/2-dependent Sp1 Phosphorylation and an Atypical cis-Acting Element in the Proximal PDGFR-α Promoter* , 2004, Journal of Biological Chemistry.

[27]  Jorma Isola,et al.  Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  K. Alitalo,et al.  Angiopoietin‐regulated recruitment of vascular smooth muscle cells by endothelial‐derived heparin binding EGF‐like growth factor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  N. Navin,et al.  WW Domain-containing Protein YAP Associates with ErbB-4 and Acts as a Co-transcriptional Activator for the Carboxyl-terminal Fragment of ErbB-4 That Translocates to the Nucleus* , 2003, Journal of Biological Chemistry.

[30]  Xiaoming Deng,et al.  Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors. , 2003, Cancer research.

[31]  T. Curran,et al.  ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  L. Mei,et al.  Presenilin-dependent γ-Secretase-like Intramembrane Cleavage of ErbB4* , 2002, The Journal of Biological Chemistry.

[33]  T. Golde,et al.  γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase , 2001, Science.

[34]  J. Määttä,et al.  Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. , 2000, Trends in cardiovascular medicine.

[35]  J. Buxbaum,et al.  Tumor Necrosis Factor-α-converting Enzyme Is Required for Cleavage of erbB4/HER4* , 2000, The Journal of Biological Chemistry.

[36]  M. Klagsbrun,et al.  A Natural ErbB4 Isoform That Does Not Activate Phosphoinositide 3-Kinase Mediates Proliferation but Not Survival or Chemotaxis* , 2000, The Journal of Biological Chemistry.

[37]  Careen K. Tang,et al.  Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo. , 1999, Cancer research.

[38]  Xin-Yuan Fu,et al.  Erbb4 Signaling in the Mammary Gland Is Required for Lobuloalveolar Development and Stat5 Activation during Lactation , 1999, The Journal of cell biology.

[39]  M. Klagsbrun,et al.  Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase , 1999, Oncogene.

[40]  Katsura Asano,et al.  Identification of a Translation Initiation Factor 3 (eIF3) Core Complex, Conserved in Yeast and Mammals, That Interacts with eIF5 , 1998, Molecular and Cellular Biology.

[41]  M. Klagsbrun,et al.  A Novel Juxtamembrane Domain Isoform of HER4/ErbB4 , 1997, The Journal of Biological Chemistry.

[42]  H. P. Fell,et al.  The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells* , 1996, The Journal of Biological Chemistry.

[43]  S. Cohen,et al.  The platelet-derived growth factor alpha-receptor is encoded by a growth-arrest-specific (gas) gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Y. Yarden,et al.  An Immunological Approach Reveals Biological Differences between the Two NDF/Heregulin Receptors, ErbB-3 and ErbB-4 (*) , 1996, The Journal of Biological Chemistry.

[45]  R. Shiekhattar,et al.  Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA. , 1995, Genomics.

[46]  E. Bongcam-Rudloff,et al.  Molecular cloning and functional characterization of the human platelet-derived growth factor alpha receptor gene promoter. , 1995, Oncogene.

[47]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[48]  F. C. Lucibello,et al.  Suppression of the growth factor-mediated induction of c-fos and down-modulation of AP-1-binding activity are not required for cellular senescence. , 1993, Oncogene.

[49]  D. Slamon,et al.  Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor. , 1992, Oncogene.

[50]  C. Stiles,et al.  Retinoic acid promotes transcription of the platelet-derived growth factor alpha-receptor gene , 1990, Molecular and cellular biology.

[51]  J. Wasmuth,et al.  Efficient procedure for transferring specific human genes into Chinese hamster cell mutants: interspecific transfer of the human genes encoding leucyl- and asparaginyl-tRNA synthetases , 1983, Molecular and cellular biology.

[52]  H. Herschman,et al.  Variants of 3T3 cells lacking mitogenic response to epidermal growth factor. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Ross,et al.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[54]  B. Goldberg.  Electron microscopic studies of procollagen from cultured human fibroblasts , 1974 .

[55]  M. Hollmén,et al.  Potential of ErbB4 antibodies for cancer therapy. , 2010, Future oncology.

[56]  J. Bartlett,et al.  The ERBB 4 / HER 4 Intracellular Domain 4 ICD Is a BH 3-Only Protein Promoting Apoptosis of Breast Cancer Cells , 2006 .

[57]  L. Marrero,et al.  Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities. , 2005, The Journal of biological chemistry.

[58]  R. Weigel,et al.  Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. , 2004, Cancer research.

[59]  L. Khachigian,et al.  Fibroblast growth factor-2 represses platelet-derived growth factor receptor-alpha (PDGFR-alpha) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-alpha promoter. , 2004, The Journal of biological chemistry.

[60]  M. Burow,et al.  The ERBB 4 / HER 4 receptor tyrosine kinase regulates gene expression by functioning as a STAT 5 A nuclear chaperone , 2004 .

[61]  G. Carpenter,et al.  ErbB-4 Ectodomain Cleavage Ectodomain Cleavage of ErbB-4: Characterization of the Cleavage Site and m80 Fragment , 2003 .

[62]  L. Mei,et al.  Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. , 2002, The Journal of biological chemistry.

[63]  J. Buxbaum,et al.  Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. , 2000, The Journal of biological chemistry.